tiprankstipranks
Avidity Biosciences price target raised to $45 from $40 at BofA
PremiumThe FlyAvidity Biosciences price target raised to $45 from $40 at BofA
1M ago
Avidity Biosciences files to sell $300M in common stock
PremiumThe Fly
Avidity Biosciences files to sell $300M in common stock
1M ago
Avidity Biosciences price target raised to $56 from $38 at Leerink
PremiumThe Fly
Avidity Biosciences price target raised to $56 from $38 at Leerink
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
2M ago
Avidity Biosciences reports Q1 EPS (79c), consensus (78c)
PremiumThe FlyAvidity Biosciences reports Q1 EPS (79c), consensus (78c)
2M ago
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
PremiumPress Releases
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
2M ago
Avidity gets FDA Breakthrough Therapy designation for delpacibart etedesiran
PremiumThe Fly
Avidity gets FDA Breakthrough Therapy designation for delpacibart etedesiran
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100